____________________________________________________

N E W S R E L E A S E

Contact:
Douglas B. Chappell
Chief Financial Officer
(615) 250-1770

 
 
 
 
AMBULATORY SERVICES OF AMERICA, INC.
COMPLETES PURCHASE OF MAJORITY INTEREST IN
ROSA OF GEORGIA, LLC
 

Nashville, Tennessee (January 7, 2009) - - Ambulatory Services of America, Inc. announced that it had completed the purchase of additional interests in ROSA of Georgia, LLC, a joint venture between ASA’s subsidiary, Radiation Oncology Services of America, Inc, and American Oncology Associates, LLC.  Following the purchase, Radiation Oncology Services of America will own a majority interest in ROSA of Georgia.   
 
ROSA of Georgia offers state-of-the-art cancer treatment services, including intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and high dose rate brachytherapy in its outpatient facilities.  The joint venture was formed in March 2007; it owns and operates eight radiation oncology centers in Georgia and Florida.  Four of ROSA of Georgia's facilities are affiliated with the Georgia Center for Total Cancer Care, the largest provider of oncology/hematology services in the Southeast and a national leader in cancer treatment and research.  American Professional Associates, LLC - - a physician practice including 16 radiation oncologists - - will continue to provide physician services to patients being treated at the facilities and to serve as medical director of the facilities.


“As our relationship with ASA and ROSA has grown and matured, we have seen firsthand the benefits of having a strong, national company as a partner,” said Dale McCord, M.D., President and Chief Executive Officer of American Professional Associates and American Oncology Associates.  “We look forward to transitioning to the next phase of that relationship.

Timothy Martin, President and Chief Executive Officer of ASA, said, “Our partnership with American Oncology Associates has helped to raise the bar on clinical performance for the industry.  Providing the highest quality of care for our patients remains our mission, and ROSA of Georgia will continue to be focused on bringing the best treatment and service to cancer patients in Georgia and the Florida panhandle.”  
 
Ambulatory Services of America, headquartered in Brentwood, Tennessee, is a diversified health care services company that provides alternative site services in partnership with physicians.  ASA, through its primary subsidiaries Radiation Oncology Services of America, Inc. and Innovative Dialysis Systems, Inc., owns and operates 17 radiation oncology centers and 44 dialysis centers in eleven states and the territory of Guam. 

____________________________________________________

N E W S R E L E A S E

Contact:
Douglas B. Chappell
Chief Financial Officer
(615) 250-1770

 
 
 
 
 
AMBULATORY SERVICES OF AMERICA, INC.
ANNOUNCES JOINT VENTURE WITH
GULF COAST CANCER CENTERS 
 
Nashville, Tennessee (January 7, 2009) - - Ambulatory Services of America, Inc. announced the formation of ROSA of South Alabama, LLC, its seventh radiation oncology joint venture.  ROSA of South Alabama is a joint venture among Gulf Coast Cancer Center – Gulf Shores, P.C., Monroeville Radiation – Oncology, P.C., and South Alabama Radiation Oncology, P.C., and ASA’s subsidiary, Radiation Oncology Services of America, Inc. 

ROSA of South Alabama will own and operate four radiation oncology facilities in Gulf Shores, Brewton, Foley and Monroeville, Alabama. ROSA of South Alabama will offer state-of-the-art cancer treatment services, including intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and stereotactic body radiation therapy (SBRT) in the facilities.  The joint venture expects to build on Gulf Coast Cancer Centers’ legacy of providing high-quality cancer care to the residents and visitors to the south Alabama region.  The physicians currently serving patients at each facility will continue to provide physician services to patients being treated at the facilities.  William Hixson, M.D. will serve as medical director for each of the facilities.   
 
Dr. Hixson said, “When considering a partnership, we looked for a strong, growing company that not only brings business expertise to the table but, most importantly, also shares our passion for patient care.  We look forward to working with ASA and ROSA as we continue our mission of providing superior care and service to the growing number of cancer patients in the Gulf Coast area.” 
 
Timothy Martin, President and Chief Executive Officer of ASA, said, “We are pleased to welcome the physicians and staff of Gulf Coast Cancer Centers to the ASA family.  Dr. Hixson and his team are recognized in the industry as providers of high-quality cancer care through state-of-the-art technology, treatments and procedures.   We look forward to working with them to continue to provide excellent service to cancer patients in the Gulf Coast region.” 
 
Ambulatory Services of America, headquartered in Brentwood, Tennessee, is a diversified health care services company that provides alternative site services in partnership with physicians.  ASA, through its primary subsidiaries Radiation Oncology Services of America, Inc. and Innovative Dialysis Systems, Inc. owns, operates and manages facilities providing radiation oncology services and dialysis services.  After the formation of ROSA of South Alabama, ASA will own interests in and operate 17 radiation oncology centers and 44 dialysis centers in eleven states and the territory of Guam. 

____________________________________________________

N E W S R E L E A S E

Contact:
Douglas B. Chappell
Chief Financial Officer
(615) 250-1770

  
 
 
 
RADIATION ONCOLOGY SERVICES OF AMERICA, INC.
ANNOUNCES FORMATION OF SCIENTIFIC ADVISORY BOARD
 
Nashville, Tennessee (September 18, 2008) - - Radiation Oncology Services of America, Inc. (ROSA), a subsidiary of SAB_GroupAmbulatory Services of America, Inc., announced today the inaugural meeting of its Scientific Advisory Board in Dallas, Texas on September 12, 2008.  The Scientific Advisory Board is comprised of a diverse group of leaders in the radiation oncology field.  It will advise ROSA on numerous scientific and clinical issues including research initiatives, practice patterns and emerging technologies.  Board members include:  Lawrence R. Coia, M.D., of East Coast Radiation Oncology Associates in Toms River, New Jersey; Dennis E. Hallahan, M.D., Chair of Radiation Oncology at Vanderbilt University in Nashville, Tennessee; Richard T. Hoppe, M.D., Chair of Radiation Oncology at Stanford University in Stanford, California; George E. Laramore, Ph.D., M.D., Chair of Radiation Oncology at the University of Washington in Seattle, Washington; Erich Randolph, M.D., of Atlanta Oncology Associates in Atlanta, Georgia; and J. Warner Ray, M.D., of Radiation Oncology Services in Atlanta, Georgia.

The inaugural meeting was led by Vincent W. Dennis, M.D., Senior Medical Advisor for Ambulatory Services of America whoSAB_Working said, “The Scientific Advisory Board will be a key instrument in positioning ROSA to improve its services to our radiation oncology partners and their patients now and in the future.”  Greg Merrill, Chief Operating Officer of ROSA, also participated and said, “The formation of the Scientific Advisory Board is another important step in ROSA’s commitment to build a healthcare company of the highest quality using a physician-driven approach complemented by an experienced management team.”    

Tim Martin, President and Chief Executive Officer of ROSA’s parent company, Ambulatory Services of America, said, “Physician leadership is essential to making sure that the best technology is available for the right patients at the right time.  Bringing physician leaders together to be part of that important work is a key ROSA objective.”

Radiation Oncology Services of America, Inc., headquartered in Brentwood, Tennessee owns interests in, operates and manages 13 radiation therapy facilities in five states.  Ambulatory Services of America, Inc., headquartered in Brentwood, Tennessee, is a diversified health care services company that provides alternative site services in partnership with physicians.  ASA, through its primary subsidiaries Radiation Oncology Services of America, Inc. and Innovative Dialysis Systems, Inc. owns interests in, operates and manages a total of more than 50 facilities providing radiation oncology services and dialysis services in ten states and the territory of Guam.   

Go to Previous News